Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Tax Provisions: 2019

Historic Tax Provisions for Allogene Therapeutics (ALLO) over the last 1 years, with Dec 2019 value amounting to -$131,000.

  • Allogene Therapeutics' Tax Provisions was N/A to -$131,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$398,000, marking a year-over-year change of. This contributed to the annual value of $443,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Allogene Therapeutics' Tax Provisions is -$131,000, which was down 496.97% from $33,000 recorded in Q3 2019.
  • Allogene Therapeutics' 5-year Tax Provisions high stood at $33,000 for Q3 2019, and its period low was -$200,000 during Q2 2019.
  • Moreover, its 1-year median value for Tax Provisions was -$115,500 (2019), whereas its average is -$99,500.